Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.

अन्य संस्करण दिखाएं (1)

Eosinophilic bronchitis is a common cause of chronic cough, which like asthma is characterized by sputum eosinophilia, but in contrast to asthma there is no variable airflow obstruction or airway hyperresponsiveness. Our hypothesis was that the differences in airway pathophysiology maybe due to less...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Brightling, C, Ward, R, Woltmann, G, Bradding, P, Sheller, JR, Dworski, R, Pavord, I
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2000

समान संसाधन

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma
द्वारा: Brightling, C, और अन्य
प्रकाशित: (2000)

Induced sputum eicosanoid concentrations in asthma.
द्वारा: Pavord, I, और अन्य
प्रकाशित: (1999)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
द्वारा: Berry, M, और अन्य
प्रकाशित: (2004)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
द्वारा: Brightling, C, और अन्य
प्रकाशित: (2003)

Induced sputum inflammatory mediator concentrations in chronic cough.
द्वारा: Birring, S, और अन्य
प्रकाशित: (2004)

Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
द्वारा: Brightling, C, और अन्य
प्रकाशित: (1999)

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
द्वारा: Siddiqui, S, और अन्य
प्रकाशित: (2007)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
द्वारा: Green, R, और अन्य
प्रकाशित: (2002)

Chemokine concentrations and mast cell chemotactic activity in BAL fluid in patients with eosinophilic bronchitis and asthma, and in normal control subjects.
द्वारा: Woodman, L, और अन्य
प्रकाशित: (2006)

Eosinophilic bronchitis - what is it and why is it important?
द्वारा: Brightling, C, और अन्य
प्रकाशित: (2000)

Non-eosinophilic corticosteroid unresponsive asthma.
द्वारा: Pavord, I, और अन्य
प्रकाशित: (1999)

Eosinophilic bronchitis is an important cause of chronic cough.
द्वारा: Brightling, C, और अन्य
प्रकाशित: (1999)

Eosinophils in asthma and other allergic diseases.
द्वारा: Wardlaw, A, और अन्य
प्रकाशित: (2000)

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
द्वारा: Green, R, और अन्य
प्रकाशित: (2002)

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
द्वारा: Brightling, C, और अन्य
प्रकाशित: (2002)

Eosinophilic bronchitis: an important cause of prolonged cough.
द्वारा: Brightling, C, और अन्य
प्रकाशित: (2000)

Asthma exacerbations and sputum eosinophil counts.
द्वारा: Currie, G, और अन्य
प्रकाशित: (2003)

Eosinophilic bronchitis: clinical features, management and pathogenesis.
द्वारा: Birring, S, और अन्य
प्रकाशित: (2003)

Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry.
द्वारा: Woltmann, G, और अन्य
प्रकाशित: (1999)

Prednisone-dependent asthma: inflammatory indices in induced sputum.
द्वारा: Pizzichini, M, और अन्य
प्रकाशित: (1999)

Eosinophils in asthma and airway hyperresponsiveness.
द्वारा: Brightling, C, और अन्य
प्रकाशित: (2004)

Observational study of the natural history of eosinophilic bronchitis.
द्वारा: Berry, M, और अन्य
प्रकाशित: (2005)

Mepolizumab in refractory eosinophilic asthma.
द्वारा: Pavord, I, और अन्य
प्रकाशित: (2010)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
द्वारा: Berry, M, और अन्य
प्रकाशित: (2007)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
द्वारा: Brightling, C, और अन्य
प्रकाशित: (2000)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
द्वारा: Haldar, P, और अन्य
प्रकाशित: (2009)

Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease.
द्वारा: Bafadhel, M, और अन्य
प्रकाशित: (2012)

Alternatives to induced sputum for identifying inflammatory subtypes of asthma.
द्वारा: Simpson, J, और अन्य
प्रकाशित: (2017)

Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics.
द्वारा: Macfarlane, A, और अन्य
प्रकाशित: (2000)

The significance of eosinophilic airway inflammation in asthma
द्वारा: Pavord, I, और अन्य
प्रकाशित: (2002)

Sputum Il-17a levels correlate with biomarkers of non-eosinophilic inflammation in patients with asthma
द्वारा: Hynes, G, और अन्य
प्रकाशित: (2017)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
द्वारा: Shrimanker, R, और अन्य
प्रकाशित: (2017)

Increased sputum and bronchial biopsy IL-13 expression in severe asthma.
द्वारा: Saha, S, और अन्य
प्रकाशित: (2008)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
द्वारा: Shrimanker, R, और अन्य
प्रकाशित: (2017)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
द्वारा: Bilocca, D, और अन्य
प्रकाशित: (2017)

New insights into the relationship between airway inflammation and asthma.
द्वारा: Wardlaw, A, और अन्य
प्रकाशित: (2002)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
द्वारा: Berry, M, और अन्य
प्रकाशित: (2005)

Glucocorticoids and mepolizumab in eosinophilic asthma.
द्वारा: Bel, E, और अन्य
प्रकाशित: (2014)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
द्वारा: Kulkarni, N, और अन्य
प्रकाशित: (2010)

Eosinophils in Asthma and Airway Hyperresponsiveness [3] (multiple letters)
द्वारा: Brightling, C, और अन्य
प्रकाशित: (2004)